Acromegaly Clinical Trials

A listing of Acromegaly medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Advanced Research
Peoria Arizona 85381

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

California

UCLA School of Medicine
Los Angeles California 90095

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Coastal Metabolic Research Center University Medical Center, Dept. of Endocrinology
Ventura California 93003

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Additional Locations California

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

La Jolla California 92037

A Phase 4 clinical study for patients using Pasireotide

Los Angeles California 90048

A Phase 4 clinical study for patients using Pasireotide

Los Angeles California 90048

Patients are needed to participate in a clinical research study evaluating Sandostatin LAR for the treatment of Acromegaly

Stanford California 94304

A Phase 4 clinical study for patients using Pasireotide

Torrance California 90502

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Ventura California 93003

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Colorado

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Illinois

Chicago Illinois 60611

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Maryland

Johns Hopkins University School of Medicine Division of Endocrinology, Diabetes & Metabolism
Baltimore Maryland 21287

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Boston Massachusetts 02114

A clinical trial seeking patients for a research study for the treatment of Acromegaly

Michigan

University of Michigan Medical Center Rares de la Surrénale, Service d'Endocrinologie, Hôpital Cochin
Ann Arbor Michigan 48109

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Ann Arbor Michigan 48109-0944

A Phase 4 clinical study for patients using Pasireotide

Nevada

Las Vegas Nevada 89148

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

New Mexico

University of New Mexico HSC
Albuquerque New Mexico 87131

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

New York

Icahn School of Medicine at Mount Sinai
New York New York 10029

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

New York New York 10032

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

New York New York 10032

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Ohio

Cleveland Clinic Endocrinology
Cleveland Ohio 44195

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

CarePoint East
Columbus Ohio 43203

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Columbus Ohio 43203

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Oregon

Oregon Health & Science University
Portland Oregon

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Pennsylvania

University of Pennslyvania Smilow Center for Translational Research
Philadelphia Pennsylvania 19104-5160

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

UPDATED

Pittsburgh Pennsylvania 15212

A clinical trial seeking patients for a research study for the treatment of Acromegaly

Philadelphia Pennsylvania 19107

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Pittsburgh Pennsylvania 15212

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Pittsburgh Pennsylvania 15212

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Rhode Island

Rhode Island Hospital, Hallett Center for Diabetes and Endocrinology
East Providence Rhode Island 02914

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Tennessee

Nashville Tennessee 37212-8210

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Nashville Tennessee 37203

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Texas

Houston Texas 77030

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Houston Texas 77030

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Virginia

Chesapeake Virginia 23321

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Chesapeake Virginia 23321

A Phase 4 clinical study for patients using Pasireotide

Washington

Swedish Neuroscience Research
Seattle Washington 98122

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Seattle Washington

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Seattle Washington 98104

A Phase 4 clinical study for patients using Pasireotide

Belgium

Universitair Ziekenhuis
Brussels International 1090

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

UZLeuven Dienst endocrinologie
Leuven International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Canada

Centre hospitalier de l'Université de Montréal (CHUM)
Montreal International H2W 1T8

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

St. Paul's Hospital/Vancouver General Hospital
Vancouver International V6Z 1Y6

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Denmark

Aarhus University Hospital
Aarhus International 8000

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Copenhagen University Hospital
Copenhagen International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

France

Endocrinologie, Pavillon des Ecrins Centre Hospitalier Universitaire, Hopital Nord
Cedex International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Hôpital de la TIMONE Department of Endocrinology and Reference Center for Rare Pituitary Diseases
Marseille International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Centre de Réference Maladies Rares de la Surrénale, Service d'Endocrinologie, Hôpital Cochin
Paris International 75014

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome